Pesquisar
Kenvue Inc
KVUEAdicionar à lista de desejos
17.220USD
-0.370-2.10%
Horário de mercado （ET）Cotações atrasadas em 15 min
33.06BValor de mercado
20.36P/L TTM
Mais detalhes de Kenvue Inc Empresa
Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
Informações de Kenvue Inc
Código da empresaKVUE
Nome da EmpresaKenvue Inc
Data de listagemMay 04, 2023
CEOPerry (Kirk L)
Número de funcionários22000
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 04
Endereço1 Kenvue Way
CidadeSUMMIT
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal07901
Telefone19088741200
Sitehttps://www.kenvue.com
Código da empresaKVUE
Data de listagemMay 04, 2023
CEOPerry (Kirk L)
Executivos da empresa Kenvue Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
111.42K
+12.47%
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
93.62K
+8.09%
Mr. Kirk L. Perry
Mr. Kirk L. Perry
Chief Executive Officer, Director
Chief Executive Officer, Director
76.92K
+18.68%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
61.45K
+28.19%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
61.41K
+7.07%
Mr. Larry J. Merlo
Mr. Larry J. Merlo
Independent Chairman of the Board
Independent Chairman of the Board
40.94K
--
Mr. Matthew Orlando
Mr. Matthew Orlando
General Counsel
General Counsel
38.49K
+4.31%
Mr. Michael E. Sneed
Mr. Michael E. Sneed
Independent Director
Independent Director
37.10K
+70.93%
Mr. Jan Meurer
Mr. Jan Meurer
Group President, North America
Group President, North America
33.18K
+13.30%
Ms. Charmaine England
Ms. Charmaine England
Chief Growth Officer
Chief Growth Officer
29.06K
+5.38%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
111.42K
+12.47%
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
93.62K
+8.09%
Mr. Kirk L. Perry
Mr. Kirk L. Perry
Chief Executive Officer, Director
Chief Executive Officer, Director
76.92K
+18.68%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
61.45K
+28.19%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
61.41K
+7.07%
Mr. Larry J. Merlo
Mr. Larry J. Merlo
Independent Chairman of the Board
Independent Chairman of the Board
40.94K
--
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Face and Body Care
2.87B
19.00%
Other Self Care
2.42B
16.00%
Pain Care
1.97B
13.00%
Cough, Cold and Allergy
1.97B
13.00%
Other Essential Health
1.66B
11.00%
Outro
4.23B
28.00%
Por RegiãoUSD
Nome
Receita
Proporção
Northern America
7.26B
48.00%
Europe, Middle East, and Africa
3.72B
24.60%
Asia - Pacific
2.77B
18.35%
Latin America
1.37B
9.05%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Face and Body Care
2.87B
19.00%
Other Self Care
2.42B
16.00%
Pain Care
1.97B
13.00%
Cough, Cold and Allergy
1.97B
13.00%
Other Essential Health
1.66B
11.00%
Outro
4.23B
28.00%
Distribuição de ações
Atualizado em: dom, 10 de mai
Atualizado em: dom, 10 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Vanguard Capital Management, LLC
6.48%
State Street Investment Management (US)
6.19%
BlackRock Institutional Trust Company, N.A.
4.97%
Vanguard Portfolio Management, LLC
4.82%
Fidelity Management & Research Company LLC
4.08%
Outro
73.46%
Investidores
Investidores
Proporção
Vanguard Capital Management, LLC
6.48%
State Street Investment Management (US)
6.19%
BlackRock Institutional Trust Company, N.A.
4.97%
Vanguard Portfolio Management, LLC
4.82%
Fidelity Management & Research Company LLC
4.08%
Outro
73.46%
Tipos de investidores
Investidores
Proporção
Investment Advisor
47.48%
Investment Advisor/Hedge Fund
24.61%
Hedge Fund
12.78%
Research Firm
3.25%
Sovereign Wealth Fund
2.46%
Pension Fund
2.07%
Bank and Trust
1.95%
Family Office
0.45%
Family Office
0.19%
Outro
4.76%
Participação acionária institucional
Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
2195
1.82B
94.75%
-195.89M
2025Q4
2178
1.89B
98.39%
-351.03M
2025Q3
2127
1.94B
100.91%
-295.23M
2025Q2
2098
1.93B
100.46%
-321.30M
2025Q1
2078
1.95B
101.47%
-298.35M
2024Q4
1944
1.96B
102.60%
-253.31M
2024Q3
1828
1.91B
99.61%
-331.64M
2024Q2
1723
1.90B
99.19%
-79.08M
2024Q1
1598
1.90B
99.47%
-51.94M
2023Q4
1442
1.89B
98.66%
-22.82M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
State Street Investment Management (US)
118.87M
6.2%
+4.06M
+3.54%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
95.38M
4.98%
-2.02M
-2.07%
Dec 31, 2025
Fidelity Management & Research Company LLC
78.37M
4.09%
+4.52M
+6.12%
Dec 31, 2025
MFS Investment Management
64.89M
3.39%
-18.70M
-22.37%
Dec 31, 2025
Pentwater Capital Management LP
56.72M
2.96%
+35.64M
+169.07%
Dec 31, 2025
Geode Capital Management, L.L.C.
49.86M
2.6%
+371.32K
+0.75%
Dec 31, 2025
Independent Franchise Partners LLP
48.15M
2.51%
+17.34M
+56.31%
Dec 31, 2025
Norges Bank Investment Management (NBIM)
43.88M
2.29%
+18.20M
+70.88%
Dec 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
Renaissance IPO ETF
7.13%
American Century Focused Large Cap Value ETF
3.3%
VanEck Morningstar Wide Moat Value ETF
3.29%
ProShares Ultra Consumer Staples
2.91%
TBG Dividend Focus ETF
2.75%
Brookstone Value Stock ETF
2.2%
Invesco S&P 500 Equal Weight Consumer Staples ETF
2.13%
MarketDesk Focused US Dividend ETF
1.93%
Consumer Staples Select Sector SPDR Fund
1.84%
VanEck Morningstar Wide Moat ETF
1.76%
Ver Mais
Renaissance IPO ETF
Proporção7.13%
American Century Focused Large Cap Value ETF
Proporção3.3%
VanEck Morningstar Wide Moat Value ETF
Proporção3.29%
ProShares Ultra Consumer Staples
Proporção2.91%
TBG Dividend Focus ETF
Proporção2.75%
Brookstone Value Stock ETF
Proporção2.2%
Invesco S&P 500 Equal Weight Consumer Staples ETF
Proporção2.13%
MarketDesk Focused US Dividend ETF
Proporção1.93%
Consumer Staples Select Sector SPDR Fund
Proporção1.84%
VanEck Morningstar Wide Moat ETF
Proporção1.76%
Dividendo
Um total de
2.32B
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Apr 29, 2026
KVUE.NB Interim Cash Dividend of gross USD 0.2075 paid on May 27, 2026 going ex on May 13, 2026
May 13, 2026
May 27, 2026
May 13, 2026
Jan 28, 2026
KVUE.NB Interim Cash Dividend of gross USD 0.2075 paid on Feb 25, 2026 going ex on Feb 11, 2026
Feb 11, 2026
Feb 25, 2026
Feb 11, 2026
Oct 29, 2025
KVUE.NB Final Cash Dividend of gross USD 0.2075 paid on Nov 26, 2025 going ex on Nov 12, 2025
Nov 12, 2025
Nov 26, 2025
Nov 12, 2025
Jul 30, 2025
KVUE.NB Interim Cash Dividend of gross USD 0.2075 paid on Aug 27, 2025 going ex on Aug 13, 2025
Aug 13, 2025
Aug 27, 2025
Aug 13, 2025
Apr 16, 2025
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on May 28, 2025 going ex on May 14, 2025
May 14, 2025
May 28, 2025
May 14, 2025
Jan 16, 2025
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Feb 26, 2025 going ex on Feb 12, 2025
Feb 12, 2025
Feb 26, 2025
Feb 12, 2025
Oct 17, 2024
KVUE.NB Final Cash Dividend of gross USD 0.205 paid on Nov 27, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 27, 2024
Nov 13, 2024
Jul 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Aug 28, 2024 going ex on Aug 14, 2024
Aug 14, 2024
Aug 28, 2024
Aug 14, 2024
Apr 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on May 22, 2024 going ex on May 07, 2024
May 08, 2024
May 22, 2024
May 07, 2024
Jan 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 28, 2024 going ex on Feb 13, 2024
Feb 14, 2024
Feb 28, 2024
Feb 13, 2024
Ver Mais
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
